Epitomee Medical Ltd
Tel Aviv Stock Exchange EPIT.TA
Epitomee Medical Ltd Net Income for the year ending December 31, 2023: USD -1.56 M
Epitomee Medical Ltd Net Income is USD -1.56 M for the year ending December 31, 2023, a 64.22% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.
-
Epitomee Medical Ltd Net Income for the year ending December 31, 2022 was USD -4.37 M, a -17.99% change year over year.
-
Epitomee Medical Ltd Net Income for the year ending December 31, 2021 was USD -3.71 M, a -276.32% change year over year.
-
Epitomee Medical Ltd Net Income for the year ending December 31, 2020 was USD -985.00 K, a 2.33% change year over year.
-
Epitomee Medical Ltd Net Income for the year ending December 31, 2019 was USD -1.01 M.
Key data
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Net Income Margin |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: EPIT.TA
| CEO | Dr. Radan Hashimshony Ph.D. |
| IPO Date | Dec. 15, 2021 |
| Location | Israel |
| Headquarters | 19 Tarshish |
| Employees | 42 |
| Sector | Health Care |
| Industries | |
Description
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email